Streetbeat News

Regulatory

FXI

SPY

The U.S. has urged China to be more transparent with its economic data amid concerns of a slowdown in the Chinese economy. This comes as investors globally are closely watching China's economic health, which could have significant implications for global markets.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 8:08 pm

LFCR

Lifecore Biomedical has received a notice from Nasdaq regarding a delay in their annual report. The company has until October 16, 2023, to submit a plan to regain compliance with the Listing Rule.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 8:06 pm

PNW

Mizuho Securities analyst Anthony Crowdell has upgraded Pinnacle West Capital Corp (PNW) to Buy from Neutral and increased the price target to $85 from $78. The analyst expects Arizona's increasingly constructive regulation and load growth to push PNW's earnings and P/E premium upward. The company's FY23 EPS guidance has been raised to $4.10-$4.30 from $3.95-$4.15.

Portfolio Pulse from Lekha Gupta

August 22, 2023 | 7:58 pm

HLGN

Heliogen has been granted U.S. Patent #11732928 for a 'Receiver For Capturing Solar Energy'. Following this news, the company's shares have seen a significant increase.

Portfolio Pulse from Happy Mohamed

August 22, 2023 | 7:58 pm

LYT

Lytus Technologies has received a notification from Nasdaq about its noncompliance with Listing Rule 5250(c)(1). The company has not yet disclosed the details of the noncompliance.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 7:45 pm

FULC

Fulcrum Therapeutics announced that the FDA has lifted the clinical hold on its FTX-6058 for sickle cell disease, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 7:37 pm

REGN

Regeneron Pharmaceuticals has announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to support the development of a next-generation COVID-19 monoclonal antibody therapy. The agreement is part of 'Project NextGen,' an initiative by the U.S. Department of Health and Human Services to advance new vaccines and therapeutics for COVID-19. The new contract has an estimated value of up to approximately $326 million of government funding.

Portfolio Pulse from Happy Mohamed

August 22, 2023 | 6:18 pm

C

NVDA

SFTBF

SFTBY

British chip designer Arm Ltd, backed by SoftBank Group Corp, has filed for an IPO with valuations estimated between $60 billion and $70 billion. This comes amidst a year of reduced IPOs and after a failed deal to sell the company to Nvidia Corporation due to antitrust concerns. Despite a marginal decrease in revenue and net income for the fiscal year ending this March, Arm's overall profitability and market standing remain strong. The IPO could potentially signal a resurgence in the IPO market, but experts urge caution due to Arm's unique position in the market.

Portfolio Pulse from AJ Fabino

August 22, 2023 | 5:40 pm

FOX

FOXA

RUM

A recent Morning Consult poll shows President Biden leading against both Donald Trump and Florida Governor Ron DeSantis in hypothetical 2024 election matchups. Biden's lead over DeSantis has grown as DeSantis' support among Republican voters has dropped. Trump, despite being indicted four times in 2023, continues to dominate the GOP field. The first Republican primary debate will be aired on Fox News and livestreamed on Rumble Inc, with Trump sitting out.

Portfolio Pulse from Chris Katje

August 22, 2023 | 5:09 pm

SPY

President Biden will attend the G20 Leaders' Summit in New Delhi, India, from September 7-10. The summit will focus on joint efforts to tackle global issues, including clean energy transition and combating climate change.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 4:37 pm